JPS6434914A - Tablet and manufacture - Google Patents

Tablet and manufacture

Info

Publication number
JPS6434914A
JPS6434914A JP63176872A JP17687288A JPS6434914A JP S6434914 A JPS6434914 A JP S6434914A JP 63176872 A JP63176872 A JP 63176872A JP 17687288 A JP17687288 A JP 17687288A JP S6434914 A JPS6434914 A JP S6434914A
Authority
JP
Japan
Prior art keywords
diluent
humectant
active component
tablet
salbutamol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63176872A
Other languages
English (en)
Japanese (ja)
Inventor
Suunatsuku Mitsushieru
Buugare Jiyoeru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Publication of JPS6434914A publication Critical patent/JPS6434914A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP63176872A 1987-07-16 1988-07-15 Tablet and manufacture Pending JPS6434914A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8710048A FR2618073B1 (fr) 1987-07-16 1987-07-16 Comprimes de type a matrice hydrophile a base de salbutamol et leur procede de preparation

Publications (1)

Publication Number Publication Date
JPS6434914A true JPS6434914A (en) 1989-02-06

Family

ID=9353198

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63176872A Pending JPS6434914A (en) 1987-07-16 1988-07-15 Tablet and manufacture

Country Status (9)

Country Link
US (1) US5132116A (index.php)
EP (1) EP0299877B1 (index.php)
JP (1) JPS6434914A (index.php)
AT (1) ATE73324T1 (index.php)
CA (1) CA1330041C (index.php)
DE (1) DE3869002D1 (index.php)
ES (1) ES2039285T3 (index.php)
FR (1) FR2618073B1 (index.php)
GR (1) GR3004752T3 (index.php)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5155383A (en) * 1992-02-03 1992-10-13 Motorola, Inc. Circuit and method of resetting a master/slave flipflop
JP2002541090A (ja) * 1999-03-31 2002-12-03 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 制御放出製剤中の前糊化澱粉

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2666506A1 (fr) * 1990-09-07 1992-03-13 Pf Medicament Comprime a liberation prolongee a base de 5-mononitrate d'isosorbide et son procede de preparation.
US5298261A (en) * 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
DE4329794C2 (de) * 1993-09-03 1997-09-18 Gruenenthal Gmbh Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US5662933A (en) * 1993-09-09 1997-09-02 Edward Mendell Co., Inc. Controlled release formulation (albuterol)
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
BR9507872A (pt) * 1994-05-13 1997-09-23 Smithkline Beecham Corp Método e composição para aumentar a absorção de cálcio
US5945125A (en) * 1995-02-28 1999-08-31 Temple University Controlled release tablet
AU2068797A (en) * 1996-01-29 1997-08-20 Edward Mendell Co. Inc. Sustained release excipient
EP0859603B1 (en) 1996-07-08 2008-12-17 Penwest Pharmaceuticals Co. Sustained release matrix for high-dose insoluble drugs
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
IT1297461B1 (it) * 1997-10-29 1999-12-17 Ciocca Maurizio Preparazione di compresse a rilascio controllato a base di complessi tra carragenano e farmaci basici solubili
MXPA01005370A (es) * 1999-09-30 2004-05-14 Penwest Pharmaceuticals Co Sistema de matriz de liberacion sostenida para farmacos altamente solubles.
CN1551770A (zh) * 2001-07-06 2004-12-01 ������ҩ�����޹�˾ 羟吗啡酮控释制剂
TWI338583B (en) * 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation
KR101655455B1 (ko) * 2005-09-09 2016-09-07 안젤리니 라보팜 엘엘씨 일일 1회 투여를 위한 트라조돈 조성물
AU2006308448A1 (en) * 2005-09-09 2007-05-03 Labopharm (Barbados) Limited Sustained drug release composition
US20070160960A1 (en) * 2005-10-21 2007-07-12 Laser Shot, Inc. System and method for calculating a projectile impact coordinates

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1338235A (en) * 1970-12-15 1973-11-21 May & Baker Ltd Azapurinones
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
FR2525474A1 (fr) * 1982-04-26 1983-10-28 Roussel Uclaf Nouvelle forme pharmaceutique orale de clometacine
FR2535202B1 (fr) * 1982-11-03 1985-08-09 Fabre Sa Pierre Comprimes de theophylline a liberation controlee et leur procede de fabrication
AU4064285A (en) * 1984-03-21 1985-10-11 American Home Products Corporation Sustained release pharmaceutical capsules
GB8514665D0 (en) * 1985-06-11 1985-07-10 Eroceltique Sa Oral pharmaceutical composition
GB8521494D0 (en) * 1985-08-29 1985-10-02 Zyma Sa Controlled release tablet
GB8613689D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
US4824677A (en) * 1986-12-18 1989-04-25 The Unjohn Company Grooved tablet for fractional dosing of sustained release medication
DE3720757A1 (de) * 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5155383A (en) * 1992-02-03 1992-10-13 Motorola, Inc. Circuit and method of resetting a master/slave flipflop
JP2002541090A (ja) * 1999-03-31 2002-12-03 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 制御放出製剤中の前糊化澱粉

Also Published As

Publication number Publication date
DE3869002D1 (de) 1992-04-16
GR3004752T3 (index.php) 1993-04-28
ATE73324T1 (de) 1992-03-15
EP0299877A1 (fr) 1989-01-18
FR2618073A1 (fr) 1989-01-20
US5132116A (en) 1992-07-21
CA1330041C (fr) 1994-06-07
FR2618073B1 (fr) 1990-09-07
EP0299877B1 (fr) 1992-03-11
ES2039285T3 (es) 1993-09-16

Similar Documents

Publication Publication Date Title
JPS6434914A (en) Tablet and manufacture
DE69904575T2 (de) Zusammensetzung, herstellung und verwendung von siliciumnitrid als biomaterial für medizinische zwecke
DE60115703T2 (de) Poröser kalziumphosphatzement
GB2197329B (en) Hard tissue substitute composition
US4846838A (en) Prosthetic body for bone substitute and a method for the preparation thereof
JPS51106114A (index.php)
Dos Santos et al. Dual‐setting calcium phosphate cement modified with ammonium polyacrylate
DE4016135A1 (de) Haertendes gemisch
CA2220008A1 (en) Composition and method for tumor imaging
GB8920534D0 (en) Antiviral compounds
Song et al. Cytotoxicity of newly developed pozzolan cement and other root-end filling materials on human periodontal ligament cell
GR3032800T3 (en) Active substance complex for the production of biological parts, especially organs for living organisms; process for its production and its use.
EP0425298A3 (en) Sustained-release preparation of basic medical agent hydrochloride
Vogelgesang et al. Polyneuropathy in juvenile dermatomyositis
AU4492393A (en) Bone-related carboxypeptidase-like protein and process for its production
YU143985A (en) Process for making solid composition for oral use based on niphedipine with controlled dismission of active substance
Escolar et al. Structure and composition of canine urinary calculi
DE4103876C2 (de) Verfahren zur Fixierung einer körnigen Knochen-Prothese und Kit zur Herstellung einer körnigen Knochen-Prothesezusammensetzung zur Verwendung in dem Fixierungsverfahren
LTIP1590A (en) Process for the preparing thienopyrane derivatives
EP0373613A3 (en) Pyridine-3-percarboxylic acid monopersulfate
ES2019024A6 (es) Procedimiento de preparar una composicion farmaceutica a base de trimebutina.
HUT46842A (en) Biocompatible layered body containing calcium phosphate and method for producing same
Villani et al. Model of doxorubicin-induced cardiomyopathy in the rat.
JP3423951B2 (ja) リン酸カルシウム系硬化体用粉剤
DE69323465D1 (de) Sulfatase-ähnliches Protein aus Knochen und Verfahren zu dessen Herstellung